​Aster completes 5% QCIL stake acquisition via share swap with BCP Asia II, Centella

Azad Moopen, CMD, Aster Health Care Ltd
| Photo Credit:
PAUL NORONHA

Aster DM Healthcare has announced the completion of its acquisition of 5 per cent stake in Quality Care India Ltd (QCIL) from BCP Asia II TopCo IV Pte. Ltd. (BCP) and Centella Mauritius Holdings Ltd. (Centella) through a share swap. This comes ahead of QCIL’s merger with Aster DM Healthcare. The merged entity, ‘Aster DM Quality Care’, will be jointly controlled by Aster Promoters and BCP.

The transaction was completed by acquiring 1,90,46,028 equity shares of QCIL by Aster DM Healthcare from BCP and TPG for a value of ₹849.13 crore. As discharge of the total purchase consideration is payable, Aster DM Healthcare has allotted 1,86,07,969 equity shares (face value ₹10 each) to BCP and Centella.

The share swap has been undertaken pursuant to receipt of necessary approvals, including shareholder consent, in-principal approval from BSE and NSE, and CCI approval and is subject to the final listing and trading approval from BSE and NSE for the new equity shares allotted to BCP and Centella by Aster, stated the company.

Azad Moopen, Founder & Chairman, Aster DM Healthcare, said, “The acquisition of 5 per cent stake in QCIL through a share swap is the first step toward the strategic merger between Aster DM Healthcare and QCIL. This move lays the foundation for a unified, future-ready healthcare network with a strengthened pan-India presence. As we progress toward full integration, our focus remains firm towards creating significant long-term value for all our stakeholders.”      

The newly issued shares will have equal rights (pari passu) with existing equity shares of Aster. The shares of Aster were down by 0.72 per cent at ₹508 on the BSE.

Published on April 30, 2025